<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  4<BR>                    <BR>                  CONTRAINDICATIONS<BR>               <BR>               <BR>                  Femara may cause fetal harm when administered to a pregnant woman and the clinical benefit to premenopausal women with breast cancer has not been demonstrated. Femara is contraindicated in women who are or may become pregnant. If Femara is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus. [see Use in Specific Populations (8.1)]<BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        Women of premenopausal endocrine status, including pregnant women (4)<BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>